L'intérêt à découvert pour Spectral AI donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Spectral AI. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Spectral AI (NASDAQ:MDAI) Stock, Rapport sur les intérêts à découvert

Spectral AI

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Spectral AI Inc

William Blair analyst Brian Drab downgrades Valmont Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) from Outperform to Market Perform.

News

Downgrades

Analyst Ratings

William Blair Downgrades Valmont Industries to Market Perform

Macro Economic Events

Economics

Federal Reserve

Fed's Goolsbee Says Tariffs Raise Prices And Reduce Output, Which Is A Stagflationary Impulse; The Hard Data Right Now Are Not The Stagflation Of The 1970s, But It Is Uncomfortable When Inflation And Unemployment Are Both Moving Higher

Fed's Goolsbee Says Uncertainty Could Feed Into Company Capital Plans, Also Sap Confidence; Say Evidence Is Mixed On How Sentiment Influences Activity, But Contacts In The Midwest Say Confidence Is Changing How They Behave

Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) remains the undisputed scale leader in <a href="https://www.benzinga.com/topic/payments">the payments industry</a>, but Mastercard Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) has been outpacing its rival in growth.
Should investors bet on Visa's dominance or Mastercard's momentum?
JPMorgan's Tien-tsin Huang analyzes the key differences between the two payment giants, focusing on their financials, shareholder returns, and valuation dynamics.
<h2 class="wp-block-heading">Scale Vs. Speed: Who Wins?</h2>
Visa's dominance is clear — it boasts 63% more total volume, 31% more revenue, and an enviable ten-point operating margin advantage, thanks to superior fixed cost leverage. It also has 50% more cards outstanding and commands nearly two-thirds of the global market share in purchase volume.
However, Mastercard has been running circles around Visa in growth, capitalizing on a mix of faster-expanding regions and revenue streams. According to Huang, Mastercard outpaced Visa in revenue growth by about two percentage points, maintaining its five-year average edge. Even on the bottom line, Mastercard's adjusted EPS grew four percentage points faster, thanks to margin expansion—something Visa couldn't pull off last year.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44081480/stripes-payment-surge-puts-adyen-paypal-fiserv-on-notice-ai-stablecoins-fuel-the-race">Stripe&#8217;s Payment Surge Puts Adyen, PayPal, Fiserv On Notice &#8211; AI, Stablecoins Fuel The Race</a>
<h2 class="wp-block-heading">Shareholder Returns: A Dead Heat</h2>
Both companies are cash flow powerhouses, returning nearly all of their adjusted net income to shareholders via aggressive share buybacks. In 2024, Mastercard and Visa shares gained 23% and 21%, respectively, mirroring the S&amp;P 500's performance. 
However, Huang notes that Visa has taken the early lead in 2025, benefiting from investors' appetite for U.S. growth and a reduced regulatory overhang.
<h2 class="wp-block-heading">The Valuation Puzzle</h2>
Network multiples have expanded, with Mastercard trading at 33x forward earnings versus Visa's 28x. 
While both remain in line with their historical premium to the S&amp;P 500, Huang points out that Mastercard's higher multiple reflects its stronger growth profile, while Visa's relative value case is gaining traction.
<h2 class="wp-block-heading">The Verdict</h2>
Huang isn't picking sides, maintaining an Overweight rating on both stocks. Mastercard's growth premium looks sustainable, but Visa's relative value and easing regulatory risks could make it the safer bet. 
Investors have a choice—go big with Visa or go fast with Mastercard. Either way, it's a battle of titans worth watching.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/25/03/44429586/elon-musk-says-hang-on-to-your-stock-in-surprise-late-evening-tesla-all-hands-meeting-touts-7-million-evs-optimus-robot-and-ai-supercomputer-dojo">Elon Musk Says &#8216;Hang On To Your Stock&#8217; In Surprise Late-Evening Tesla All-Hands Meeting — Touts 7 Million EVs, Optimus Robot, And AI Supercomputer Dojo</a></li>
</ul>
Image: Shutterstock

Analyst Color

Long Ideas

Trading Ideas

Visa Vs. Mastercard: The Battle For Payment Supremacy Heats Up

Maxim Group analyst Jason McCarthy initiates coverage on Anixa Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIX#NASDAQ">ANIX</a>) with a Buy rating and announces Price Target of $10.

Price Target

Initiation

ANIX

Maxim Group Initiates Coverage On Anixa Biosciences with Buy Rating, Announces Price Target of $10

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
<h3 class="wp-block-heading">Ellington Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFC#NYSE">EFC</a>)</h3>
<ul>
<li>Dividend Yield: 11.62%</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained an Outperform rating and increased the price target from $13.75 to $14.5 on March 3, 2025. This analyst has an accuracy rate of 72%.</li>
<li>JMP Securities analyst Aaron Hecht reiterated a Market Outperform rating with a price target of $14 on Jan. 23, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Recent News: On Feb. 27, Ellington Financial posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">EFC news</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/0d7a4bbe-568a-425e-9de9-24d4a367e5c1" alt="" style="width:521px;height:auto" /></a></figure>
<h3 class="wp-block-heading">AllianceBernstein Holding L.P. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>)</h3>
<ul>
<li>Dividend Yield: 8.55%</li>
<li>Barclays analyst Benjamin Budish maintained an Equal-Weight rating and cut the price target from $39 to $36 on Dec. 9, 2024. This analyst has an accuracy rate of 78%.</li>
<li>TD Cowen analyst Bill Katz maintained a Buy rating and increased the price target from $41 to $42 on Nov. 25, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On March 11, Equitable Holdings announced a cash tender offer for up to 46 million units of AllianceBernstein at $38.50 per unit.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">latest AB news</a> </li>
</ul>
<h3 class="wp-block-heading">Capital Southwest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSWC#NASDAQ">CSWC</a>)</h3>
<ul>
<li>Dividend Yield: 11.43%</li>
<li>B. Riley Securities analyst Bryce Rowe maintained a Neutral rating and raised the price target from $24 to $24.5 on Oct. 30, 2024. This analyst has an accuracy rate of 62%.</li>
<li>JMP Securities analyst Brian McKenna downgraded the stock from Market Outperform to Market Perform on May 15, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On Feb. 18, Capital Southwest named CFO Michael Sarner to succeed Bowen Diehl as President and CEO.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">CSWC news</a> </li>
</ul>

<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/03/44414749/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-march">Top 2 Defensive Stocks That May Keep You Up At Night In March</a></li>
</ul>

Dividends

Pre-Market Outlook

Markets

CSWC

Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields

Fed's Goolsbee Says The Response To Stagflation Would Depend On A Number Of Factors, But Expectations Would Be Very Important

Fed's Goolsbee Says The Fed Is Commitment To 2% Inflation Is Rock Solid; Say If Market Expectations Of Long Run Inflation Start Rising The Fed Would Have To Act; Says There Is Nothing More Uncomfortable Than A Stagflationary Environment; There Is No Generic Answer To It

WIIM

F&G Annuities shares are trading lower after the company announced a common stock offering consisting of 8 million shares.

On CNBC's &#8220;Halftime Report Final Trades,&#8221; Joshua Brown of Ritholtz Wealth Management named Chevron Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) <a href="https://www.benzinga.com/markets/25/02/43685595/chevron-announces-about-20-workforce-reduction-in-cost-saving-initiative-responsible-leadership-requires-taking-these-steps">his final trade</a>.
On Feb. 12, Chevron announced plans to slash its workforce by up to 20% and intends to commence major layoffs this year, aiming to complete the majority by the end of 2026. The move is part of a broader cost-cutting plan, with the company targeting a reduction of $2 billion to $3 billion by the end of 2026, reported CNBC
Jason Snipe of Odyssey Capital Advisors said he likes Fiserv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>). On March 19, Fiserv announced that it had acquired CCV, a payment solutions provider in the Netherlands, Belgium and Germany, to drive growth in the European market.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jim Lebenthal of Cerity Partners picked UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) as his final trade.
On Thursday, UnitedHealth Group's Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturer pricing actions. The company plans a full implementation by January 2028.
Price Action:
<ul>
<li>Chevron shares gained 0.4% to close at $164.77 on Thursday.</li>
<li>Fiserv rose 0.7% to settle at $221.79 during Thursday's session.</li>
<li>UnitedHealth Group shares gained 1.6% to close at $511.30 on Thursday.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/03/44414749/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-march">Top 2 Defensive Stocks That May Keep You Up At Night In March</a></li>
</ul>
Photo: Shutterstock

Media

Chevron, Fiserv And A Health Care Stock On CNBC's 'Final Trades'

Loop Capital analyst Garik Shmois downgrades Beacon Roofing Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NASDAQ">BECN</a>) from Buy to Hold and announces $124 price target.

BECN

Loop Capital Downgrades Beacon Roofing Supply to Hold, Announces $124 Price Target

NIO shares are trading lower after the company reported worse-than-expected Q4 financial results and issued Q1 revenue guidance below estimates.

B. Riley Securities analyst Christopher Souther maintains Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) with a Buy and raises the price target from $5 to $6.

AMPX

B. Riley Securities Maintains Buy on Amprius Technologies, Raises Price Target to $6

As President <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a>&#8216;s tariffs shake up <a href="https://www.benzinga.com/markets/25/03/44411483/jamie-dimon-says-theres-a-lot-of-turbulence-out-there-amid-trump-tariffs-inflation-woes-and-geopolitical-risks">domestic industries</a> and rip up longstanding trade agreements with countries near and far, a certain billion-dollar industry might ultimately find itself in the green. 
If you guessed the cannabis industry, go to the head of the class.
Derek Chase, CEO of Los Angeles-based FLORA+BAST, contends that the unintended consequences of tariffs could push businesses toward more eco-conscious, locally sourced solutions. Chase quite likes the idea of developing home-grown solutions.
"Having more domestic options is a positive consequence of this extra tax layer and makes our USA-made goods more price competitive since our competition will likely want to raise prices to maintain profitability," he told Benzinga.
"But yes, since we love our Mexican suppliers and only aim to grow that part of the business, the 25% does pose higher costs for us. That said, the cost of packaging v. the price of our goods is a much smaller ratio than someone selling, say, peanuts," Chase said. 
Trump's 25% across-the-board tariffs on Mexico and Canada were enacted on March 4, though they were paused two days later until April 2. Then, on March 12, <a href="https://www.benzinga.com/news/25/03/44281882/canada-retaliates-with-20b-in-tariffs-on-us-goods-amid-trade-war">Canada retaliated</a> to Trump's steel and aluminum duties by imposing 25% tariffs on over $20 billion worth of U.S. goods.
"The short-term costs for a lot of businesses will be greatly impacted, but we believe this will bring more manufacturing back to the states and provide more options for eco-conscious businesses, especially those using glass," Chase said in an interview. 
George Sadler, CEO of Gelato Canna Co., says the tariffs will not negatively affect his business any more than any other business.
"Everyone will be affected so we will be on a level playing field. Most of our manufacturing products and final packaging are made in the United States. It will be the end user, the consumer that will feel the increase. We can only absorb so much in this volatile cannabis market."
JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO <a href="https://www.benzinga.com/topic/jamie-dimon">Jamie Dimon</a>, who <a href="https://www.benzinga.com/news/legal/25/01/43247421/jamie-dimon-says-jpmorgan-chase-probably-would-provide-services-to-cannabis-industry-once-federal-laws-permit">recently indicated</a> that the largest bank in the U.S.&nbsp;"probably would" provide banking services to marijuana businesses if/when federal laws permit, <a href="https://www.benzinga.com/markets/25/03/44411483/jamie-dimon-says-theres-a-lot-of-turbulence-out-there-amid-trump-tariffs-inflation-woes-and-geopolitical-risks">said this week</a> that the economy is in a &#8220;soft landing&#8221; phase, "but there's a lot of turbulence out there."
Despite the turbulence, Derek Chase remains optimistic. "All in all, it's a good thing — short-term price pressure should force businesses to look at domestic options and for businesses to sprout up in categories where they could not compete historically."
Now Read:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/03/44427511/elon-musk-ted-cruz-joke-about-cannabis-on-podcast-should-i-pull-out-a-joint-to-boost-rating">Elon Musk, Ted Cruz Joke About Cannabis On Podcast: Should I &#8216;Pull Out A Joint&#8217; To Boost Ratings?</a></li>
</ul>
Photo: Shutterstock

Cannabis

Government

Politics

Exclusives

Interview

Trump's Tariffs Could Boost A Surprising Billion-Dollar Industry

B. Riley Securities analyst Anna Glaessgen maintains Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) with a Buy and lowers the price target from $70 to $65.

B. Riley Securities Maintains Buy on Academy Sports, Lowers Price Target to $65

Loop Capital analyst Rick Paterson downgrades FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) from Hold to Sell and lowers the price target from $283 to $221.

Loop Capital Downgrades FedEx to Sell, Lowers Price Target to $221

B. Riley Securities analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) with a Buy and lowers the price target from $127 to $122.

LNTH

B. Riley Securities Maintains Buy on Lantheus Holdings, Lowers Price Target to $122

MNSO

MINISO Group Holding shares are trading lower following a Q2 sales miss.

Fed's Goolsbee Says The Answer To What "Transitory" Means This Time Around Is Whether The Tariffs Apply To Intermediate Goods, Stoke Retaliation, And Other Factors; Still Believe The Economy Is Resilient And If There Is Progress On Inflation Rates Will Be Lower In 12 To 18 Months; When There Is Uncertainty It Is A Time To Get As Much Data As Possible

A record number of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) vehicles have been traded this month, following protests against CEO Elon Musk&#8217;s role with the Donald Trump administration and the Department of Government Efficiency (DOGE), as per data from Edmunds.
What Happened: Tesla cars from model year 2017 or newer accounted for 1.4% of all the vehicles traded in until March 15, a significant increase from 0.4% in March last year, reported Reuters.
Analysts at Edmunds predict that this share could grow through the second half of the month.
Activists across the U.S. have staged Tesla Takedown demonstrations over Musk&#8217;s role in cuts to the federal workforce and cancellation of contracts that fund global humanitarian programs.
See Also:<a href="https://www.benzinga.com/25/03/44394560/elon-musks-tesla-targeted-with-arson-attacks-in-las-vegas-kansas-city-report"> Elon Musk&#8217;s Tesla Targeted With Arson Attacks In Las Vegas, Kansas City: Report</a>
This has led to a surge in Tesla trade-ins, with social media posts showing Tesla owners giving up their vehicles in displays of anger toward Musk.
&#8220;Brand loyalty is becoming a bigger question mark as factors such as Elon Musk&#8217;s increasing public involvement in government&#8230;leave some longtime owners feeling disconnected from the brand,&#8221; said Jessica Caldwell, Edmunds&#8217; head of insights.
Anger against the brand has escalated to the point of Tesla vehicles being set on fire and damage to the company&#8217;s showrooms and charging stations. Tesla&#8217;s stock has nearly halved from its January peak.
Why It Matters: This surge in trade-ins comes amid a series of setbacks for Tesla. There has been a significant<a href="https://www.benzinga.com/news/global/25/03/44128646/tesla-sales-drop-in-europe-in-february-some-countries-down-over-40-is-musks-political-push-hurting-ev-company"> drop</a> in Tesla sales in Europe, with some countries experiencing a decline of over 40%.
Furthermore, the company's Cybertruck is also<a href="https://www.benzinga.com/markets/equities/25/03/44429500/teslas-cybertruck-sales-at-just-47k-is-really-bad-for-250k-target-says-ross-gerber-amid-recall-troubles"> struggling</a>, with figures significantly below company projections. This was followed by a<a href="https://www.benzinga.com/markets/equities/25/03/44414187/elon-musks-tesla-recalls-over-46000-cybertrucks-due-to-safety-concerns"> recall</a> affecting 46,096 Cybertruck vehicles due to safety concerns.
Adding to the company&#8217;s woes, insurance premiums for Tesla vehicles are at risk of an<a href="https://www.benzinga.com/markets/equities/25/03/44432174/tesla-owners-might-have-to-pay-more-for-insurance-amid-a-surge-in-attacks-on-elon-musk-led-ev-giants-vehicles-expert"> increase</a> due to a surge in vandalism against the company&#8217;s vehicles, fuelled by resentment towards Musk over his role with the Trump administration.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44432174/tesla-owners-might-have-to-pay-more-for-insurance-amid-a-surge-in-attacks-on-elon-musk-led-ev-giants-vehicles-expert">Tesla Owners Might Have To Pay More For Insurance Amid A Surge In Attacks On Elon Musk-Led EV Giant&#8217;s Vehicles: Expert</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Tech

TSLA

Tesla Record Highest Trade-Ins Amid Backlash Against CEO Elon Musk, Surge In Vandalism

Press Releases

Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants

Spectral AI Provides Update to Investors

Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study

General

Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study

Small Cap

Opinion

FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape

Financing

Spectral AI Strengthens Financial Position Ahead of FDA Submission

CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

Spectral AI Completes Three Device Installations in Australia

Health Care

Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

IPOs

Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP

ABSI

AVAI

GEHC

MDAI

MDAIW

TREN

HC Wainwright & Co.

Northland Capital Markets

BTIG

Screenshot 2024-06-04 at 5.43.27 PM

Biotech

Revolutionizing Wound Care With Spectral AI - See How This AI Company Is Changing Critical Diagnostics

Comments

Spectral AI

Intérêt court

Spectral AI (NASDAQ:MDAI) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL